I’m pleased to announce that we have added GLP-compliant testing to our service offering. We focus on custom testing and method development early in the development process, especially for medical device, drug, and biologic manufacturers in the wound care and regenerative medicine space. GLP capability adds an additional level of quality review and assurance for…

iFyber has recently started offering a cytokine panel to our clients. Please take a look at our latest whitepaper by Tricia Conti and Nina Bionda. The assay provides a nice screening tool when developing new wound care or regenerative therapies. Learn more here.

iFyber’s website has had a refresh since it launched it’s current iteration in 2017. We’re highlighting our current focus on contract research in the Wound Care, Medical Devices, Regenerative Medicine and Chemical Detection arenas.

iFyber will be showcasing their service offerings at MD&M West this week in Anaheim, CA’s convention center. Meet Greg Mouchka and Robert DeMaio and learn how iFyber can help set up you company with custom lab testing solutions. Booth 1077.